Article
Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells
26 Oct 2020
Abstract excerpt
Among all cancers, glioblastoma (GBM) remains one of the least treatable. One key factor in this resistance is a subpopulation of tumor cells termed glioma stem cells (GSCs). These cells are highly resistant to current treatment modalities, possess marked self-renewal capacity, and are considered key drivers of tumor recurrence. Further complicating an understanding of GBM, evidence shows that the GSC population...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
